2025 annual financial data
Inovio Pharmaceuticals 2025 Net margin
Direct answer
Net margin was -130,000%.
Operating income was -86,822,104 USD and net income was -84,945,901 USD.
Operating cash flow was -88,629,430 USD.
Get free Inovio Pharmaceuticals email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 65,343 USD
- Operating income
- -86,822,104 USD
- Net income
- -84,945,901 USD
- Operating cash flow
- -88,629,430 USD
Explore related company data
View all 2025 financial metricsView RevenueView Operating incomeView Net incomeView Operating cash flowView Revenue growthView Operating income growthView Net income growthView Operating cash flow growthView Operating marginView Operating cash flow marginView all Inovio Pharmaceuticals financial years